Furthermore, it must be considered that IL-4, a classical type 2 cytokine, may induce type 1 immunity, increasing survival of glioma-bearing mice and decreasing tumorigenicity of sarcoma cell in vivo [44,45]. This evidence concerns the gene IL4 and sarcoma.